CLIMARA

This brand name is authorized in United States. It is also authorized in Australia, Canada, Estonia, Ireland, Italy, New Zealand, Poland, South Africa, Turkey.

Active ingredients

The drug CLIMARA contains one active pharmaceutical ingredient (API):

1	Estradiol UNII 4TI98Z838E - ESTRADIOL
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CLIMARA Patch	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8125P, 8126Q, 8485N, 8486P
CA	Health Products and Food Branch	02231509, 02247499, 02247500
EE	Ravimiamet	1026672, 1063437
IT	Agenzia del Farmaco	030183014
NZ	Medicines and Medical Devices Safety Authority	7304, 7305, 8736, 8737
PL	Rejestru Produktów Leczniczych	100194047
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546813919, 8699546814091
US	FDA, National Drug Code	50419-451, 50419-452, 50419-453, 50419-454, 50419-456, 50419-459
ZA	Health Products Regulatory Authority	29/21.8.1/0610, 29/21.8.1/0611